2Berelowitz M, Schade DS, Fischette C, et al. Comparative efficacy of a once-deily controlled -release formulation of glipizide and immediate-release glipizide in patients with NIDDM.Diabetes Care 1994k,17:1460.
3Simonson DC, Kourides IA, Feinglos M, et al. Efficacy ,safety ,and doseresponse chaaracterisstics of glipizide gastrointestinal therapeutic system on glycemic control and inslin secretion in NIIDDM.Results of two muiticenter,randomized,placebo-controlled clinical trials.Diabetes Care 1997,20:597.
4Testa MA, Simonson DC. Beneficial effects of improved glycemic control with glipizide GITS on quality of life and symptom distress in NIDDM Diabetes, 1996;45;27:123A.
5Riddle MC,McDaniel PA, Tive LA. Glipizlde-GITS does not increase the hypoglycemic effect of mild exercise during fasting in NIDDM.Diabetes Care.1997,20:992.
